0 0 2 minutes read
Adar Poonawala admitted that he is under a lot of pressure.
Adar Poonawala, CEO of Serum Institute of India, the world’s largest vaccine manufacturer, tweeted last night about an “excellent meeting” with “our partners in the UK” as they face a major challenge to meet India’s vaccine demands . He said that he would return to the country in a few days.
Developed in partnership with Serum Institute of India’s Kovishield – Oxford University and British-Swedish pharma giant AstraZeneca – India is one of the three vaccines that India has introduced in Kovaxin of Biotech and Sputnik V of Russia. In addition to 1.5 lakh doses of Sputnik V approved for emergency use. The one who got approval last month reached India last night. The country is breaking previous world records with an alarming daily increase in Kovid cases; More than 4.01 lakh cases were reported yesterday.